William Crowe1, Lulu Wang1, Zhongwei Zhang1, Jasmina Varagic2, J Daniel Bourland1,3, Michael D Chan3, Amyn A Habib4, Dawen Zhao1,5. 1. a Department of Biomedical Engineering , Wake Forest School of Medicine , Winston-Salem , NC , USA. 2. b Department of Surgery , Wake Forest School of Medicine , Winston-Salem , NC , USA. 3. c Department of Radiation Oncology , Wake Forest School of Medicine , Winston-Salem , NC , USA. 4. d Department of Neurology and Neurotherapeutics , University of Texas Southwestern Medical Center and VA North Texas Medical Center , Dallas , TX , USA. 5. e Department of Cancer Biology , Wake Forest School of Medicine , Winston-Salem , NC , USA.
Abstract
PURPOSE: To assess early changes in brain metastasis in response to whole brain radiotherapy (WBRT) by longitudinal Magnetic Resonance Imaging (MRI). MATERIALS AND METHODS: Using a 7T system, MRI examinations of brain metastases in a breast cancer MDA-MD231-Br mouse model were conducted before and 24 hours after 3 daily fractionations of 4 Gy WBRT. Besides anatomic MRI, diffusion-weighted (DW) MRI and dynamic contrast-enhanced (DCE) MRI were applied to study cytotoxic effect and blood-tumor-barrier (BTB) permeability change, respectively. RESULTS: Before treatment, high-resolution T2-weighted images revealed hyperintense multifocal lesions, many of which (∼50%) were not enhanced on T1-weighted contrast images, indicating intact BTB in the brain metastases. While no difference in the number of new lesions was observed, WBRT-treated tumors were significantly smaller than sham controls (p < .05). DW MRI detected significant increase in apparent diffusion coefficient (ADC) in WBRT tumors (p < .05), which correlated with elevated caspase 3 staining of apoptotic cells. Many lesions remained non-enhanced post WBRT. However, quantitative DCE MRI analysis showed significantly higher permeability parameter, Ktrans, in WBRT than the sham group (p < .05), despite marked spatial heterogeneity. CONCLUSIONS: MRI allowed non-invasive assessments of WBRT induced changes in BTB permeability, which may provide useful information for potential combination treatment.
PURPOSE: To assess early changes in brain metastasis in response to whole brain radiotherapy (WBRT) by longitudinal Magnetic Resonance Imaging (MRI). MATERIALS AND METHODS: Using a 7T system, MRI examinations of brain metastases in a breast cancerMDA-MD231-Brmouse model were conducted before and 24 hours after 3 daily fractionations of 4 Gy WBRT. Besides anatomic MRI, diffusion-weighted (DW) MRI and dynamic contrast-enhanced (DCE) MRI were applied to study cytotoxic effect and blood-tumor-barrier (BTB) permeability change, respectively. RESULTS: Before treatment, high-resolution T2-weighted images revealed hyperintense multifocal lesions, many of which (∼50%) were not enhanced on T1-weighted contrast images, indicating intact BTB in the brain metastases. While no difference in the number of new lesions was observed, WBRT-treated tumors were significantly smaller than sham controls (p < .05). DW MRI detected significant increase in apparent diffusion coefficient (ADC) in WBRT tumors (p < .05), which correlated with elevated caspase 3 staining of apoptotic cells. Many lesions remained non-enhanced post WBRT. However, quantitative DCE MRI analysis showed significantly higher permeability parameter, Ktrans, in WBRT than the sham group (p < .05), despite marked spatial heterogeneity. CONCLUSIONS: MRI allowed non-invasive assessments of WBRT induced changes in BTB permeability, which may provide useful information for potential combination treatment.
Authors: Tormod A M Egeland; Jon-Vidar Gaustad; Ida K Vestvik; Ilana C Benjaminsen; Berit Mathiesen; Einar K Rofstad Journal: Magn Reson Med Date: 2006-04 Impact factor: 4.668
Authors: Rong Zhou; Stephen Pickup; Thomas E Yankeelov; Charles S Springer; Jerry D Glickson Journal: Magn Reson Med Date: 2004-08 Impact factor: 4.668
Authors: Samuel A Sprowls; Tasneem A Arsiwala; Jacob R Bumgarner; Neal Shah; Sundus S Lateef; Brooke N Kielkowski; Paul R Lockman Journal: Trends Cancer Date: 2019-07-20
Authors: Natalie J Serkova; Kristine Glunde; Chad R Haney; Mohammed Farhoud; Alexandra De Lille; Elizabeth F Redente; Dmitri Simberg; David C Westerly; Lynn Griffin; Ralph P Mason Journal: Cancer Res Date: 2020-12-01 Impact factor: 13.312
Authors: Mika L Persson; Alicia M Douglas; Frank Alvaro; Pouya Faridi; Martin R Larsen; Marta M Alonso; Nicholas A Vitanza; Matthew D Dun Journal: Neuro Oncol Date: 2022-09-01 Impact factor: 13.029
Authors: Manuel Valiente; Amanda E D Van Swearingen; Carey K Anders; Amos Bairoch; Adrienne Boire; Paula D Bos; Diana M Cittelly; Neta Erez; Gino B Ferraro; Dai Fukumura; Brunilde Gril; Meenhard Herlyn; Sheri L Holmen; Rakesh K Jain; Johanna A Joyce; Mihaela Lorger; Joan Massague; Josh Neman; Nicola R Sibson; Patricia S Steeg; Frits Thorsen; Leonie S Young; Damir Varešlija; Adina Vultur; Frances Weis-Garcia; Frank Winkler Journal: Cancer Res Date: 2020-07-08 Impact factor: 12.701